
|Articles|May 16, 2020
ASCRS 2020: New solutions for patient, physician access from Sun Pharmaceuticals
Author(s)Alex Delaney-Gesing
Advertisement
Ophthalmology Times' Sheryl Stevenson speaks with Mark Hagler, senior vice president, head of Ophthalmics, Oncology & LTC at Sun Pharmaceuticals, on the company's ongoing research and portfolio, as well as how its operations and employees are continuing to manage and adapt amid the coronavirus pandemic, during the 2020 ASCRS virtual meeting.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
EURETINA 2026: Uveitis or retinitis pigmentosa? Ester Carreño, MD, PhD, on mimics
2
EURETINA 2026: Retinal signs as diagnostic clues to systemic metabolic disease
3
MOGENRY earns Japan priority review for inherited retinal dystrophies
4
What retinal imaging reveals about the brain-eye connection with Sharon Fekrat, MD, FACS, FASRS
5















